VPVFHIV Fees and Costs — PIMCO International Bond Portfolio (U.S. Dollar-Hedged), Administrative Class
Data updated: 2026-08-31
The net expense ratio is 1.09%: a 0.75% management fee, a 0.15% 12b-1 fee plus 0.19% other expenses. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $35K in broker commissions, 0.0065% of average net assets, and portfolio turnover was 654%.
VPVFHIV Fees and Expenses
Annual operating expenses and sales charges of VPVFHIV. Prospectus, as of December 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.75% |
| 12b-1 fee | 0.15% |
| Other expenses | 0.19% |
| Gross expense ratio | 1.09% |
| Fee waiver | — |
| Net expense ratio | 1.09% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
VPVFHIV Costs Over Time
On $10,000 invested in VPVFHIV, assuming 5% a year before costs, total costs come to $685 over 5 years, cutting the return by 1.15% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 1.09%) | $114 | $357 | $618 |
| Trading costs (broker commissions) | $1 | $2 | $4 |
| Lost growth on money paid in costs | $0 | $18 | $63 |
| Total costs | $115 | $377 | $685 |
| Value after costs | $10,385 | $11,200 | $12,078 |
| Impact on return, per year | 1.15% | 1.15% | 1.15% |
VPVFHIV Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0065%
- Total broker commissions: $35K
- Bought from dealers (principal trades, not a cost): $12.7B
- Portfolio turnover (prospectus): 654%
- Securities lending: none during the year
VPVFHIV Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Merrill Lynch, Pierce, Fenner, & Smith | $34K | 97.59% |
| Bofa Securities, Inc | $838 | 2.41% |
VPVFHIV Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Morgan Stanley & Co., Inc. | $2.7B | 22.21% |
| Goldman Sachs & Co. | $2.4B | 19.95% |
| Barclays Capital, Inc. | $2.0B | 16.87% |
| J.P. Morgan Securities LLC | $1.6B | 13.40% |
| Merrill Lynch, Pierce, Fenner, & Smith | $1.4B | 11.96% |
| Wells Fargo Securities, LLC | $549.0M | 4.56% |
| Citigroup Global Markets, Inc. | $455.0M | 3.78% |
| Mizuho Securities USA, Inc. | $445.1M | 3.70% |
| Deutsche Bank Securities, Inc. | $248.0M | 2.06% |
| BNP Paribas Securities Corp. | $182.5M | 1.52% |
PIMCO International Bond Portfolio (U.S. Dollar-Hedged) Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| VPVFHDV | Institutional Class | 0.94% | — |
| VPVFHIV | Administrative Class | 1.09% | — |
| PVITFBP | Advisor Class | 1.19% | — |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.